These programs typically work for commercially insured patients but not for those on government insurance
Specifically, the ELIXA (lixisenatide) trial studied patients with T2DM who had recent acute coronary syndrome and found that the addition of lixisenatide to conventional therapy did not result in a significant difference in cardiovascular endpoints relative to placebo (Table 1) [56]
While individual enrollees will look at their own bathroom scales to judge whether Bridge coverage of GLP-1 drugs is working for them, Congress may want more data to determine the programs future.
When you eat, GLP-1 tells your brain youre satisfied and slows down how quickly food leaves your stomach
Myth 4: The Side Effects Are Too Severe Reality Check: Yes, there are side effects, but they are generally mild and temporary
The labeled side-effect profile is the same across providers: nausea, vomiting, diarrhea, constipation, abdominal pain, and headache are common